DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U de, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002; 359: 995-1003
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.